The Anti-Inflammatory Effect of Omega-7 Against Cisplatin in Rat Model

Main Article Content

Shrouq H Mahmood
Ali F Hassan


Omega-7 (palmitoleic acid, 16:1 n7) is a monounsaturated fatty acid that is found to have several beneficial effects. Cisplatin is commonly considered for the treatment of different carcinomas. Cisplatin therapy is restricted due to its nephrotoxicity. Nephrotoxicity caused by cisplatin is thought to be associated with inflammatory reactions among other mechanisms. The aim of the present study was to evaluate the possible anti-inflammatory effect of omega-7 on cisplatin in rats. Thirty adult male Wistar Albino rats were divided randomly into five equal groups, rats of group 1 received liquid paraffin solution orally for 7 consecutive days, rats of group 2 received cisplatin (7.5 mg/kg) by single intraperitoneal injection, rats of group 3 received omega-7 (50 mg/kg) by oral administration for 7 days consecutively and then followed by single cisplatin (7.5 mg/kg) intraperitoneal injection on the eighth day, rats of group 4 received omega-7 (100 mg/kg) by oral administration for 7 days consecutively followed by single intraperitoneal injection of cisplatin (7.5 mg/kg) on the eighth day, rats of group 5 received omega-7 only (100 mg/kg) orally for 7 consecutive days. On day 9, all animals were euthanized and then serum samples were utilized for assessment of tumor necrosis factor-alpha (TNF-α), interleukin-10 (IL-10) and interleukin-1β (IL-1β). Treatment of rats with omega-7 had led to significant decline in the activities of the pro-inflammatory cytokines TNF-α and IL-1β, and significant reduction in the level of IL-10. Omega-7 has an anti-inflammatory effect against cisplatin adverse effects.


Download data is not yet available.

Article Details

How to Cite
Mahmood, S. H., & Hassan, A. F. (2022). The Anti-Inflammatory Effect of Omega-7 Against Cisplatin in Rat Model. The Iraqi Journal of Veterinary Medicine, 46(2), 48–52.


Song IB, Gu H, Han HJ, Lee NY, Cha JY, Son YK, et al. Omega-7 inhibits inflammation and promotes collagen synthesis through SIRT1 activation. Appl Biol Chem. 2018; 61(4):433–439.

Bueno-Hernández N, Sixtos-Alonso MS, Milke García MDP, Yamamoto-Furusho JK. Effect of Cis-palmitoleic acid supplementation on inflammation and expression of HNF4γ, HNF4α and IL6 in patients with ulcerative colitis. Minerva Gastroenterol Dietol. 2017; 63(3):257-263.

Ismaili N, Amzerin M, Flechon A. Chemotherapy in advanced bladder cancer: current status and future. J Hematol Oncol. 2011; 4:35.

Zarogoulidis K, Zarogoulidis P, Darwiche K, Boutsikou E, Machairiotis N, Tsakiridis K, et al. Treatment of non-small cell lung cancer (NSCLC). J Thorac Dis. 2013; 5(Suppl 4):S389-S396.

Chan BA, Coward JIG. Chemotherapy advances in small-cell lung cancer. J Thorac Dis. 2013; 5(Suppl 5):S565–S578.

Volarevic V, Djokovic B, Jankovic MG, Harrell CR, Fellabaum C, Djonov V, et al. Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity. Journal of biomedical science. 2019; 26:25.

Peres LAB, Cunha Júnior AD da. Acute nephrotoxicity of cisplatin: molecular mechanisms. Brazilian J Nephrol. 2013; 35:332–340.

Oh Ag-S, Kim H-J, Shen A, Lee S Bin, Khadka D, Pandit A, et al. Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies. Electrolytes Blood Press. 2014;12(2):55–65.

Assumaidaee AAM, Ali NM, Fadhil AA. Effect of vitamin E as α-tocopherol acetate on mercuric chloride-induced chronic oxidoreductive stress and nephrotoxicity in rats. Iraqi J Vet Med. 2019;43(2):102–118.

Azouz AA, Abdel-Razek EA-N, Abo-Youssef AM. Amlodipine alleviates cisplatin-induced nephrotoxicity in rats through gamma-glutamyl transpeptidase (GGT) enzyme inhibition, associated with regulation of Nrf2/HO-1, MAPK/NF-κB, and Bax/Bcl-2 signaling. Saudi Pharm J. 2020;28(11):1317–1325.

Madi HSMMHSAMF, Abdel-Gayoum AA. Ameliorative Effects of the Aqueous Extract of Allium porrum (Wild Leek) against Cisplatin-Induced Nephrotoxicity in Rabbits. 2021;30(2):184–177.

Aldossary SA. Review on pharmacology of cisplatin: clinical use, toxicity and mechanism of resistance of cisplatin. Biomed Pharmacol J. 2019;12(1):7–15.

Nebivolol ameliorates cisplatin‐induced nephrotoxicity in rats. Basic Clin Pharmacol Toxicol. 2016;118(6):449–455.

Allameh H, Fatemi I, Malayeri AR, Nesari A, Mehrzadi S, Goudarzi M. Pretreatment with berberine protects against cisplatin-induced renal injury in male Wistar rats. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(10):1825–1833.

Perše M, Večerić-Haler Ž. Cisplatin-induced rodent model of kidney injury: characteristics and challenges. Biomed Res Int. 2018; 2018:29–1.

Crona DJ, Faso A, Nishijima TF, McGraw KA, Galsky MD, Milowsky MI. A systematic review of strategies to prevent cisplatin‐induced nephrotoxicity. Oncologist. Oncologist. 2017;22(5):609–619.

Saleh D, Abdelbaset M, Hassan A, Sharaf O, Mahmoud S, Hegazy R. Omega-3 fatty acids ameliorate doxorubicin-induced cardiorenal toxicity: In-vivo regulation of oxidative stress, apoptosis and renal Nox4, and in-vitro preservation of the cytotoxic efficacy. PLoS One. 2020;15(11):e0242175.

Institute of Laboratory Animal Resources (US). Committee on Care, Use of Laboratory Animals. Guide for the care and use of laboratory animals. US Department of Health and Human Services, Public Health Service, National Institutes of Health; National Academies Press, Washington, DC, USA, 1986.

Greenfield EA. Sampling and preparation of mouse and rat serum. Cold Spring Harb Protoc. 2017;2017(11):pdb-prot100271.

Mostafa RE, Saleh DO, Mansour DF. Cisplatin-induced nephrotoxicity in rats: modulatory role of simvastatin and rosuvastatin against apoptosis and inflammation. J Appl Pharm Sci. 2018;8(4):43–50.

Hoek J, Bloemendal KM, Van der Velden L-AA, Van Diessen JNA, Van Werkhoven E, Klop WMC, et al. Nephrotoxicity as a dose-limiting factor in a high-dose cisplatin-based chemoradiotherapy regimen for head and neck carcinomas. Cancers (Basel). 2016;8(2):21.

Browning RJ, Reardon PJT, Parhizkar M, Pedley RB, Edirisinghe M, Knowles JC, et al. Drug delivery strategies for platinum-based chemotherapy. ACS Nano. 2017;11(9):8560–8578.

Yousef MI, Hussien HM. Cisplatin-induced renal toxicity via tumor necrosis factor-α, interleukin 6, tumor suppressor P53, DNA damage, xanthine oxidase, histological changes, oxidative stress and nitric oxide in rats: protective effect of ginseng. Food Chem Toxicol.

; 78:17–25.

Kim P. A2 inhibits cisplatin-induced acute kidney injury by modulating regulatory T cells by the CD206 mannose receptor. Kidney Int. (88):550.

Chowdhury S, Sinha K, Banerjee S, Sil PC. Taurine protects cisplatin induced cardiotoxicity by modulating inflammatory and endoplasmic reticulum stress responses. Biofactors. 2016;42(6):647–64.

Alhoshani AR, Hafez MM, Husain S, Al-Sheikh AM, Alotaibi MR, Al Rejaie SS, et al. Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats. BMC Nephrol. 2017;18(1):1–10.

Tadagavadi RK, Reeves WB. Endogenous IL-10 attenuates cisplatin nephrotoxicity: role of dendritic cells. J Immunol. 2010;185(8):4904–4911.

Souza CO, Teixeira AAS, Biondo LA, Silveira LS, de Souza Breda CN, Braga TT, et al. Palmitoleic acid reduces high fat diet-induced liver inflammation by promoting PPAR-γ-independent M2a polarization of myeloid cells. Biochim Biophys Acta (BBA)-Molecular Cell Biol Lipids. 2020;1865(10):158776.

Wang L, Oehlers SH, Espenschied ST, Rawls JF, Tobin DM, Ko DC. CPAG: software for leveraging pleiotropy in GWAS to reveal similarity between human traits links plasma fatty acids and intestinal inflammation. Genome Biol. 2015;16(1):1–18.

Wiese DM, Horst SN, Brown CT, Allaman MM, Hodges ME, Slaughter JC, et al. Serum fatty acids are correlated with inflammatory cytokines in ulcerative colitis. PLoS One. 2016;11(5):e0156387.‎